The Cox proportional hazards model listing the significant prognostic parameters
| Covariate . | Unfavorable category . | Hazard ratio . | P . |
|---|---|---|---|
| Morphology | Plasmablastic | 2.211 | < .0001 |
| PCLI | ≥ 1% | 1.631 | < .0001 |
| β2M | ≥ 2.7 | 1.551 | .0006 |
| Naive CD4 | < 147 | 1.395 | .0026 |
| sIL-6R | ≥ 270 | 1.429 | .0034 |
| Plasma cell % | ≥ 30% | 1.371 | .0039 |
| CD19 | < 125 | 1.277 | .0381 |
| Covariate . | Unfavorable category . | Hazard ratio . | P . |
|---|---|---|---|
| Morphology | Plasmablastic | 2.211 | < .0001 |
| PCLI | ≥ 1% | 1.631 | < .0001 |
| β2M | ≥ 2.7 | 1.551 | .0006 |
| Naive CD4 | < 147 | 1.395 | .0026 |
| sIL-6R | ≥ 270 | 1.429 | .0034 |
| Plasma cell % | ≥ 30% | 1.371 | .0039 |
| CD19 | < 125 | 1.277 | .0381 |
PCLI indicates plasma cell labeling index; β2M, β2 microglobulin; sIL-6R, soluble interleukin-6 receptor.